Mindray Medical (MR) Tops Q1 EPS by 32c

Mindray Medical (NYSE: MR) reported Q1 EPS of $0.70, $0.32 better than the analyst estimate of $0.38. Revenue for the quarter came in at $141.5 million versus the consensus estimate of $125.44 million.

For earnings history and earnings-related data on Mindray Medical (MR) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c